Evaluation of effects induced by ingesting test foods on lower limb.(SBF-2023-03) - Evaluation of effects induced by ingesting test foods on lower limb.

Suntory beverage & Food limited.0 sites20 target enrollmentOctober 31, 2023

ConditionsHealthy adults

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy adults
Sponsor: Suntory beverage & Food limited.
Enrollment: 20
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

October 31, 2023

End Date

February 28, 2024

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Suntory beverage & Food limited.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•(1\)Subjects with a maximal blood pressure of less than 90 mmHg, or more than 130 mmHg. (2\)Subjects in pregnancy or lactation (3\)Subjects who donated their blood components and/or whole blood (0\.2 L) within the past 4 weeks. (4\)Males who donated their whole blood (0\.4 L) within the past 12 weeks. (5\)Females who donated their whole blood (0\.4 L) within the past 16 weeks. (6\)Males being collected in total of their blood (1\.2 L) within the past 12 months and in this research. (7\)Females being collected in total of their blood (0\.8 L) within the past 12 months and in this research. (8\)Subjects being under other clinical tests, or partook in those within the past four weeks, or will join those after the consent. (9\)Subjects who meet any of the following: (a)suffering from heart, liver, or kidney disease (including complications of other diseases) (b)having a history of cardiovascular disease (c)diabetes (d)allergic to the test food and required one (e)having a history of cancer or lymphedema (10\)Subjects with dysphagia (11\)Subjects who have a disease for which they are undergoing treatment and are taking pharmaceuticals (excluding applied drugs, OTC drugs, and quasi\-drugs), or who are likely to take pharmaceuticals (excluding applied drugs, OTC drugs, and quasi\-drugs) during the study. (12\)Subjects who are at risk of seasonal allergic symptoms during the study. (13\)Subjects who have periodically used OTC drugs, quasi\-drugs and health\-specific / functional / health foods including supplements, which might affect this study. (14\)Females whose menstrual cycle is not stable. (15\)Females who are unable to undergo testing within a certain period of time after the end of menstruation. (16\)Heavy alcohol drinkers or excessive smokers. (17\)Subject who are scheduled to work day and night shifts and night shifts during this study. (18\)Subjects who have difficulty maintaining daily routines (19\)Others who were judged as inappropriate for participation by the principal investigator.